Grants and Contributions:
Title:
Validation of Accuracy of Bladder Cancer Diagnostic Test Using Biomarkers and AI/ML Algorithms
Agreement Number:
1013787
Agreement Value:
$500,000.00
Agreement Date:
Dec 1, 2023 - Mar 31, 2025
Description:
Bladder cancer is the 6th most common cancer in men and the 17th most common cancer in women globally. Early diagnosis of bladder cancer is very important as it is associated with a higher survival rate, for both men and women. There is currently no clinically relevant detection test for bladder cancer. The goal of the Firm's bladder cancer project is to develop a highly accurate test that can detect clinically significant bladder cancer using machine learning and our extracellular vesicle (EV) detection platform. Similar to our successful prostate project we will first validate our selected bladder cancer biomarkers and then incorporate relevant clinical features using machine learning algorithms to create a risk score of disease.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5J 4P6
Reference Number:
172-2023-2024-Q3-1013787
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
707942124
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 140,000 dollars.
Amendment Date
Nov 22, 2024
Recipient's Legal Name:
Nanostics Inc.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: